Application Overview
This compound is fundamentally important in pharmaceutical research and development, primarily serving as a vital intermediate in the synthesis of Canagliflozin. Canagliflozin is a leading SGLT2 (Sodium-Glucose Co-Transporter 2) inhibitor, an oral medication widely used to treat Type 2 Diabetes Mellitus. Its unique structure is key to constructing the final active pharmaceutical ingredient (API) with the required efficacy and purity.
